Response Evaluation of Newly Diagnosed EGFR Mutated NSCLC in Tertiary Referral Cancer Center in Jakarta-Indonesia

被引：0
|
作者：
Amelia, D. A. R. [1 ]
Irawan, C. [1 ]
Rajabto, W. [1 ]
Kurniawan, A. [1 ,2 ]
Sari, C. [1 ]
Nasution, M. A. [1 ]
Djatnika, D. [1 ]
Priantono, D. [1 ]
Ariyanti, F. [1 ]
Wisman, B. A. [1 ]
Purlikasari, N. P. [1 ]
Dharmaraja, F. [2 ]
Nathalia, C. [2 ]
机构：
[1] Univ Indonesia, Fac Med, Jakarta, Indonesia
[2] Univ Pelita Harapan, Fac Med, Tangerang, Indonesia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
non-small cell lung cancer; EGFR mutation; targeted therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-69
引用
收藏
页码：S669 / S669
页数：1
相关论文
共 50 条
  • [21] Malignant peripheral nerve sheath tumors: Clinicopathological profile of 63 cases diagnosed at a tertiary cancer referral center in Mumbai, India
    Rekhi, Bharat
    Ingle, Abhijeet
    Kumar, Rajiv
    DeSouza, Maria Alina
    Dikshit, Rajesh
    Jambhekar, Nirmala A.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (04) : 611 - 618
  • [22] Evaluation of Texture Analysis Parameters in EGFR Mutated or ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
    Bluthgen, Maria V.
    Caramella, Caroline
    Rosellini, Silvia
    Leduc, Charlotte
    Facchinetti, Francesco
    Haspinger, Eva
    Ferte, Charles
    Michiels, Stefan
    Soria, Jean C.
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S703 - S703
  • [23] Final Results from REASON, a Registry for the Epidemiologic and Scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV in Germany
    Schuette, W.
    Eberhardt, W.
    von der Schulenburg, J. -M. Graf
    Dietel, M.
    Schirmacher, P.
    Zaun, S.
    Zirrgiebel, U.
    Thomas, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 89 - 89
  • [24] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CO-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND RESPONSE TO EGFR TYROSINE KINASE INHIBITORS (TKIS)
    Barnet, Megan B.
    O'Toole, Sandra
    Horvath, Lisa' G.
    Selinger, Christina
    Yu, Bing
    Trent, Ronald
    Ng, Chiu Chin
    Boyer, Michael J.
    Cooper, Wendy
    Kao, Steven
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 156 - 156
  • [25] Major pathologic response of EGFR mutated non-small cell lung cancer (NSCLC) on 1-3 G TKI.
    Moiseenko, Fedor Vladimirovich
    Kryukov, Kirill
    Myslik, Alexander
    Levchenko, Nikita
    Ivantsov, Alexander
    Aleksakhina, Svetlana
    Volkov, Nikita
    Gabina, Albina
    Shelekhova, Ksenia
    Artemeva, Elizaveta
    Moiseyenko, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Screening and evaluation of newly diagnosed cardiovascular diseases in first-trimester asymptomatic pregnant women in a tertiary antenatal care center in Turkey
    Bozkaya, Veciha Ozlem
    Kaplan, Zeynep Asli Oskovi
    Ozgu, Emre
    Engin-Ustun, Yaprak
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 23 (02): : 99 - 104
  • [27] Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
    Kraskowski, O.
    Eberhardt, W. E. E.
    Metzenmacher, M.
    Zaun, G.
    McCutcheon, A.
    Schmid, K. W.
    Schildhaus, H. -U.
    Darwiche, K.
    Aigner, C.
    Kasper, S.
    Hense, J.
    Gruenwald, V
    Wiesweg, M.
    Schuler, M.
    Pogorzelski, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 137 - 137
  • [28] Role of surgery in patients with stage IIIA non-small cell lung cancer (NSCLC): Lessons learned from a tertiary referral cancer center experience.
    Aggarwal, C.
    Egleston, B.
    Li, L.
    Borghaei, H.
    Mehra, R.
    Somaiah, N.
    Turaka, A.
    Scott, W. J.
    Langer, C. J.
    Simon, G. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
    Petr Makhov
    Igor Bychkov
    Bulat Faezov
    Alexander Deneka
    Alexander Kudinov
    Emmanuelle Nicolas
    Rohan Brebion
    Eleanor Avril
    Kathy Q. Cai
    Leonid V. Kharin
    Mark Voloshin
    Elena Frantsiyants
    Nikolay Karnaukhov
    Oleg I. Kit
    Iuliia Topchu
    Rushaniya Fazliyeva
    Anna S. Nikonova
    Ilya G. Serebriiskii
    Hossein Borghaei
    Martin Edelman
    Essel Dulaimi
    Erica A. Golemis
    Yanis Boumber
    Oncogenesis, 10
  • [30] Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
    Makhov, Petr
    Bychkov, Igor
    Faezov, Bulat
    Deneka, Alexander
    Kudinov, Alexander
    Nicolas, Emmanuelle
    Brebion, Rohan
    Avril, Eleanor
    Cai, Kathy Q.
    Kharin, Leonid V.
    Voloshin, Mark
    Frantsiyants, Elena
    Karnaukhov, Nikolay
    Kit, Oleg I.
    Topchu, Iuliia
    Fazliyeva, Rushaniya
    Nikonova, Anna S.
    Serebriiskii, Ilya G.
    Borghaei, Hossein
    Edelman, Martin
    Dulaimi, Essel
    Golemis, Erica A.
    Boumber, Yanis
    ONCOGENESIS, 2021, 10 (03)
12345